Pacific Biosciences Of California

Pacific Biosciences Of California

PACB· Manufacturing· Fiscal year ends in December

CEO pay in FY2025Stock +2.2% in FY2025

Christian O. Henry is the CEO of Pacific Biosciences Of California and was paid $4.3M in FY2025 (Dec), down 53%.

Pay$100 in the stock at the end of FY20 → $7
CEO pay is from each Pacific Biosciences Of California proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Executives3

See all
  1. 1Christian O. HenryFY2025
  2. 2Jim R. GibsonFY2025
  3. 3Mark Van OeneFY2025

Named executives and their total pay, from the Summary Compensation Table of the latest proxy.

Pay

See all

Pacific Biosciences Of California paid its 3 named executives $10.2M in total in FY2025 (Dec). CEO Christian O. Henry was paid $4.3M of that.

Name
Christian O. HenryPresident and Chief Executive Officer
Jim R. GibsonChief Financial OfficerNot disclosedNot disclosed
Mark Van OeneChief Operating Officer

of each named executive, from the Summary Compensation Table of each proxy.

Peers15

See all

The FY2025 (Dec) proxy of Pacific Biosciences Of California names 15 peer companies for pay. Among Pacific Biosciences Of California and these peers, CEO pay was the lowest of 11 and total shareholder return was the lowest of 11.

11th highest of 11in Pacific Biosciences Of California and its pay peers, FY2025 (Dec) by CEO pay:

$4.3M$13.8M

11th highest of 11in Pacific Biosciences Of California and its pay peers, FY2025 (Dec) by total shareholder return:

$7$86

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.

Board2

See all
  • Hannah A. Valantine, M.D.Director · 4 yr on the boardIndependentCorporate Governance and Nominating, Science and Technology—Paid as an executive
  • Chris Gibson, Ph.D.Director · -1 yr on the boardIndependentScience and Technology—Paid as an executive

The board of the latest proxy (FY2025).

Activity

  1. Pay
    Pacific Biosciences Of California COO pay fell 51% to $2.4M. The stock rose 2% in FY2025 (Dec).
    DEF 14A
  2. Pay
    Pacific Biosciences Of California CEO pay fell 53% to $4.3M. The stock rose 2% in FY2025 (Dec).
    DEF 14A
  3. Board
    Chris Gibson, Ph.D. joined the board of Pacific Biosciences Of California. Chris Gibson, Ph.D. now sits on 4 public boards.
    3
  4. Pay
    Pacific Biosciences Of California Former CFO pay rose 105% to $2.6M. The stock fell 60% in FY2022 (Dec).
    DEF 14A
  5. Pay
    Pacific Biosciences Of California COO pay fell 77% to $6.6M. The stock fell 60% in FY2022 (Dec).
    DEF 14A
  6. Pay
    Pacific Biosciences Of California Former Chief Commercial Officer pay rose 32% to $3.3M. The stock fell 81% in FY2024 (Dec).
    DEF 14A
  7. Pay
    Pacific Biosciences Of California CEO pay rose 14% to $9.2M. The stock fell 81% in FY2024 (Dec).
    DEF 14A
  8. Pay
    Pacific Biosciences Of California CEO pay rose 131% to $6.6M. The stock fell 60% in FY2022 (Dec).
    DEF 14A
  9. Pay
    Pacific Biosciences Of California COO pay fell 30% to $4.6M. The stock rose 20% in FY2023 (Dec).
    DEF 14A
  10. Pay
    Pacific Biosciences Of California Former Chief Commercial Officer pay fell 56% to $2.5M. The stock rose 20% in FY2023 (Dec).
    DEF 14A
  11. Pay
    Pacific Biosciences Of California CEO pay rose 22% to $8.0M. The stock rose 20% in FY2023 (Dec).
    DEF 14A

Filings6

See all
Proxy statementDEF 14AApr 23, 2026FY2025
Annual report10-KFeb 25, 2026FY2025
Proxy statementDEF 14AApr 23, 2025FY2024
Annual report10-KMar 17, 2025FY2024
Proxy statementDEF 14AApr 29, 2024FY2023
Annual report10-KFeb 28, 2024FY2023
For the press:Download CSVDownload PNGHow to use our data